MLN-120B
- Product Name
- MLN-120B
- CAS No.
- 783348-36-7
- Chemical Name
- MLN-120B
- Synonyms
- ML120B;MLN120B;MLN 120B;MLN-120B;MLN120B ，S7736;MLN120B, 10 mM in DMSO;ML120B; MLN 120B; MLN-120B;MLN120B;ML120B;MLN 120B;MLN-120B;ML 120B dihydrochloride(free base);N-(6-Chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methylnicotinamide
- CBNumber
- CB92666663
- Molecular Formula
- C19H15ClN4O2
- Formula Weight
- 366.8
- MOL File
- 783348-36-7.mol
MLN-120B Property
- storage temp.
- Store at -20°C
- solubility
- insoluble in H2O; ≥13.2 mg/mL in DMSO; ≥8.53 mg/mL in EtOH with gentle warming and ultrasonic
- form
- solid
- color
- Off-white to light yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P330Rinse mouth.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- SML1174
- Product name
- ML120B
- Purity
- ≥98% (HPLC)
- Packaging
- 5 mg
- Price
- $143
- Updated
- 2025/07/31
- Product number
- M425145
- Product name
- ML120B
- Packaging
- 25mg
- Price
- $495
- Updated
- 2021/12/16
- Product number
- A3628
- Product name
- MLN120B
- Packaging
- 5mg
- Price
- $100
- Updated
- 2021/12/16
- Product number
- A3628
- Product name
- MLN120B
- Packaging
- 10mM(in 1mL DMSO)
- Price
- $110
- Updated
- 2021/12/16
- Product number
- CS-1291
- Product name
- MLN120B
- Purity
- 99.94%
- Packaging
- 5mg
- Price
- $120
- Updated
- 2021/12/16
MLN-120B Chemical Properties,Usage,Production
Uses
ML 120B is a novel competitive inhibitor of ATP and i-kappa-kinase-2 (IKK2), key regulator in the survival, proliferation and apoptosis resistance of lymphoma cells.
Biological Activity
mln120b is a potent and effective inhibitor of iκb kinase beta subunit (ikkβ) with ic50 value of 20 μm [1].ikk is an enzyme complex which is a part of the upstream of nf-κb signal transduction cascade. it is composed of three subunits, including ikkα, ikkβ and ikkγ. the ikkβ subunit is able to phosphorylate iκbα protein. normally, iκbα protein inactivate nf-κb transcription factors and keep them sequestering in inactive state in the cytoplasm. however, once iκbα protein is phosphorylated by ikkβ subunit, the iκbα protein will be dissociated from nf-κb transcription factor and thus remove the inactivation effect. therefore, the transcription of nf-κb will be activated. this signaling pathway is involved in many immune and inflammatory processes.in multiple myeloma cell line rpmi 8226 and ina 6, treatment of mln120b resulted in the dose-dependent inhibition of ikkβ-induced iκbα protein phosphorylation and subsequent nf-κb activation. additionally, it was observed that mln120b was able to block tnf-α-induced nf-κb activation in mm.1s cell line. these observations suggested the inhibitory action of mln120b on ikkβ. [1].in mouse model, polyarthritis was introduced in footpads, where ikkβ-induced nf-κb activation might result in a serial of advert effects. oral administration of mln120b (12 mg/kg twice daily) inhibited paw swelling in a dose-dependent manner, and offered protection against arthritis-induced weight loss. therefore, it could be implied that mln120b was able to inhibit ikkβ-induced nf-κb activation [2].
in vivo
MLN120B (oral administration; 50 mg/kg; twice daily; 3 weeks) induces a reduction of shuIL-6R, marker of tumor growth, marker of tumor growth. It also leads to a rend toward prolonged survival in animals treated versus control[1].MLN120B (oral administration; 1-30 mg/kg; twice daily; 3 weeks)?inhibits paw swelling in a dose-dependent manner and offers significant protection against arthritis-induced weight loss as well as cartilage and bone erosion. NF-κB activity in arthritic joints is also reduced after MLN120B administration[2].
| Animal Model: | Two-month-old female Lewis rats[2] |
| Dosage: | 30 mg/kg, 10 mg/kg, 3 mg/kg, or 1 mg/kg |
| Administration: | Oral administration; twice daily; 3 weeks |
| Result: | Protected against bone and cartilage destruction in a rat model. |
| Animal Model: | SCID mice implanted with human fetal bone chips and then INA6 cells are directly injected into mice[1] |
| Dosage: | 50 mg/kg |
| Administration: | Oral administration; twice daily; 3 weeks |
| Result: | Inhibited human multiple myeloma cell growth in vivo. |
target
IkappaB beta
IC 50
IKKβ: 60 nM (IC50)
References
[1]. hideshima t, neri p, tassone p. mln120b, a novel ikappab kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. clin cancer res. 2006, 12(19): 5887-5894.
[2]. schopf l, savinainen a, anderson k. ikkbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. arthritis rheum. 2006, 54(10): 3163-3173.
MLN-120B Preparation Products And Raw materials
Raw materials
Preparation Products
MLN-120B Suppliers
- Tel
- Fax
- 86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2922
- Advantage
- 55
- Tel
- 021-58950125
- Fax
- (86) 21-58955996
- info@chemexpress.com
- Country
- China
- ProdList
- 7552
- Advantage
- 61
- Tel
- 400-6206333 13167063860
- Fax
- 021-50323701
- anhua.mao@aladdin-e.com
- Country
- China
- ProdList
- 25003
- Advantage
- 65
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- 025-846993838003-8003 18013301590
- Fax
- 025-84699383-8003
- njduly@126.com
- Country
- China
- ProdList
- 3249
- Advantage
- 55
- Tel
- Mobile:13665161512
- Fax
- +86-510-68873513
- Country
- China
- ProdList
- 1785
- Advantage
- 58
- Tel
- 027-87465837 19945049750
- Fax
- 027-8777-2287
- sales@finetechnology-ind.com
- Country
- China
- ProdList
- 9637
- Advantage
- 58
- Tel
- 13120367189
- Fax
- 021-50315529
- mychess007@163.com
- Country
- China
- ProdList
- 1994
- Advantage
- 55
- Tel
- 025-58849295 18951903616;
- Fax
- 025-68650336
- info@adooq.cn
- Country
- China
- ProdList
- 2990
- Advantage
- 60
- Tel
- +86-21-5821 5861
- Fax
- +86-21-5106 2861
- sales@letopharm.com
- Country
- China
- ProdList
- 2384
- Advantage
- 58